FindTrial
Sign In

Abnormal gene expression and dynamic monitoring of ctDNA in children with histiocytosis and tumors

Abnormal gene expression and dynamic monitoring of ctDNA in children with histiocytosis and tumors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074023
Enrollment
Unknown
Registered
2023-07-27
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Histiocytosis and tumor in children

Interventions

Abnormal gene expression and dynamic monitoring of ctDNA:none

Sponsors

The First Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Children aged < 18 years; Patients who meet WHO diagnostic criteria for pediatric histiocytosis and tumors; Laboratory examination, pathological examination information is complete.

Exclusion criteria

Exclusion criteria: The baseline sample is incomplete for various reasons;The investigators considered those who were not suitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Abnormal gene expression and dynamic monitoring of ctDNA;—

Countries

China

Contacts

Public ContactTang Yanlai

The First Affiliated Hospital of Sun Yat-Sen University

tangylai@mail.sysu.edu.cn+86 156 2620 2579

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026